TABLE 2.
Summary of the molecular typing data for 280 MRSA strains, January 2003 to December 2005, HGSA
| PFGE type; no. (%) of strains | SCCmec type; no. of strains | Ridom spa typingb
|
MLSTb
|
||
|---|---|---|---|---|---|
| spa type | Sequence of repeats | Allelic profile | STc | ||
| J; 225 (80.3) | IV; 224 | t032 | 26-23-23-13-23-31-29-17-31-29-17-25-17-25-16-28 | 7-6-1-5-8-8-6 | 22 |
| t747 | 26-23-23-31-29-17-31-29-17-25-17-25-16-28 | ||||
| t849 | 26-23-23-29-17-25-17-25-16-28 | ||||
| t022 | 26-23-13-23-31-29-17-31-29-17-25-17-25-16-28 | ||||
| IV vara; 1 | t032 | 26-23-23-13-23-31-29-17-31-29-17-25-17-25-16-28 | |||
| B; 33 (11.8) | IIIA; 33 | t037 | 15-12-16-02-25-17-24 | 2-3-1-1-4-4-3 | 239 |
| M; 10 (3.5) | I; 4 | t002 | 26-23-17-34-17-20-17-12-17-16 | 1-4-1-4-12-1-10 | 5 |
| II; 1 | t045 | 26-17-20-17-12-17-16 | |||
| IV; 2 | |||||
| IVA; 3 | t002 | 26-23-17-34-17-20-17-12-17-16 | 1-43-1-4-12-1-10 | 146 | |
| t509 | 26-23-17-20-17-12-17-16 | ||||
| C; 6 (2.1) | II; 6 | t018 | 15-12-16-02-16-02-25-17-24-24-24 | 2-2-2-2-3-3-2 | 36 |
| D; 2 (0.7) | IV; 2 | t186 | 07-12-21-17-13-13-34-34-33-34 | 22-1-14-23-12-4-31 | 88 |
| A; 1 (0.4) | IA; 1 | t051 | 11-19-21-12-21-17-34-24-34-22-25 | 3-3-1-12-4-4-16 | 247 |
| E; 1 (0.4) | IVA; 1 | t645 | 14-44-13-12-17-23-18-17 | 6-5-6-2-7-14-5 | 121 |
| F; 1 (0.4) | NTd; 1 | t860 | 08-16-02-25-17 | 2-3-1-1-4-4-3 | 239 |
| G; 1 (0.4) | IIIA; 1 | t021 | 15-12-16-02-16-02-25-17-24 | 2-3-1-1-4-4-3 | 239 |
a
IV var, dcs negative, ccrAB type 2.
b
spa typing and MLST were performed on representative strains of all PFGE types and subtypes.
c
Clones correspond to sequence types as follows: EMRSA-15 clone, ST22-IV; Brazilian clone, ST239-IIIA; New York/Japan clone, ST5-II; pediatric clone, ST5-IV; EMRSA-16 clone, ST36-II; Iberian clone, ST247-IA.
d
NT, nontypeable.